Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures

(2012) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection

(2012) Javier P. Gisbert et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Rescue Therapy forHelicobacter pyloriInfection 2012

(2012) Javier P. Gisbert   Gastroenterology Research and Practice

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy

(2011) Jun-Won Chung et al.   HELICOBACTER

Is Culture Necessary before First-line Treatment for Helicobacter pylori Infection?

(2011) Javier P. Gisbert   INTERNAL MEDICINE

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Helicobacter pylori Infection

(2011) Deng-Chyang Wu et al.   MEDICINE

A new, single-capsule bismuth-containing quadruple therapy

(2011) Javier P. Gisbert   Nature Reviews Gastroenterology & Hepatology

Bismuth-Containing Quadruple Therapy as Second-Line Treatment forHelicobacter pyloriInfection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea

(2010) Byoung Hwan Lee et al.   HELICOBACTER

Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis

(2010) Yuqin Li et al.   WIENER KLINISCHE WOCHENSCHRIFT

Cumulative H. pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen

(2008) Theodore Rokkas et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection

(2008) Yusuf Usta et al.   JOURNAL OF GASTROENTEROLOGY

Heat shock proteins in pancreatic diseases

(2008) Ashok Saluja et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY